The role of the vasculogenic phenotype and its associated extracellular matrix in tumor progression Implications for immune surveillance

Clinical and Applied Immunology Reviews

Volumn 3, Issue 6, 2003, Pages 263-276

  Seftor, Richard E B ^a   Seftor, Elisabeth A ^a   Hess, Angela R ^a   Meltzer, Paul S ^b   Hendrix, Mary J C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ANGIOGENESIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CELL TYPE; DNA MICROARRAY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNOSURVEILLANCE; LYMPHATIC SYSTEM; MELANOMA; MELANOMA CELL; METASTASIS; NATURAL KILLER CELL; PHENOTYPE; PHENOTYPIC PLASTICITY; PROGNOSIS; REVIEW; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR VASCULARIZATION; UPREGULATION; UVEA MELANOMA;

EID: 0038287591     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00123-X     Document Type: Review

References (50)

1. Seftor R.E.B. Seftor E.A. Hendrix M.J.C. Molecular role(s) for integrins in human melanoma invasion Cancer Metastasis Rev 18 1999 359-375.
2. Clark W.H.Jr Elder D.E. Guerry D. Epstein M.N. Green M.H. Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147-1165.
3. Clark W.H.Jr Tumor progression and the nature of cancer Br J Cancer 64 1991 631-644.
4. 3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma Am J Pathol 153 1998 1435-1442.
5. 3 expression Am J Pathol 153 1998 1347-1351.
6. Meier F. Will S. Ellwanger U. Schlagenhauff B. Schittek B. Rassner G. et-al. Clinical and laboratory investigations. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma Br J Dermatol 147 2002 62-70.
7. Marshal J.F. Rutherford D.C. Happerfield L. Hanby A. McCartney A.C.E. Newton-Bishop J. et-al Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas Br J Cancer 77 1998 522-529.
8. Hendrix M.J.C. Seftor E.A. Seftor R.E.B. Gardner L.M. Boldt H.C. Meyer M. et-al. Biological determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers Lab Invest 78 1998 153-163.
9. Hendrix M.J.C. Seftor E.A. Seftor R.E.B. Kirschmann D.A. Gardner L.M. Boldt H.C. et-al Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/sc) Am J Pathol 152 1998 855-863.
10. Maniotis A.J. Folberg R. Hess A. Seftor E.A. Gardner L.M. Pe'er J. et-al Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 3 1999 739-752.
11. Welch D.R. Bisi J.E. Miller B.E. Conaway D. Seftor E.A. Yohem K.H. et-al. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line Int J Cancer 47 1991 227-237.
12. Seftor E.A. Meltzer P.S. Kirschmann D.A. Pe'er J. Maniotis A.J. Trent J.M. et-al Molecular determinants of human uveal melanoma invasion and metastasis Clin Exp Metastasis 19 2002 233-246.
13. Bittner M. Meltzer P. Chen Y. Jiang Y. Seftor E. Hendrix M. et-al Molecular classification of cutaneous malignant melanoma by gene expression profiling Nature 406 6795 2000 536-540.
14. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis Nat Med 6 2000 389-395.
15. Risau W. Mechanisms of angiogenesis Nature 386 1997 671-674.
16. Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis N Engl J Med 333 1995 1757-1763.
17. Rak J. Kerbel R.S. Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls Cancer Metastasis Rev 15 1996 231-236.
18. Hess A.R. Seftor E.A. Gardner L.M.G. Carles-Kinch K. Schneider G.B. Seftor R.E.B. et-al Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2) Cancer Res 61 2001 3250-3255.
19. Hendrix M.J.C. Seftor E.A. Meltzer P.S. Gardner L.M.G. Hess A.R. Kirschmann D.A. et-al Seftor REB expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry Proc Natl Acad Sci USA 98 2001 8018-8023.
20. Seftor R.E.B. Seftor E.A. Koshikawa N. Meltzer P.S. Gardner L.M.G. Bilban M. et-al Cooperative interactions of laminin 5 γ2 chain, matrix metalloproteinase-2, and membrane type-1 matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma Cancer Res 61 2001 6322-6327.
21. Hynes R.O. Specificity of cell adhesion in development: the cadherin superfamily Curr Opin Genet Dev 2 1992 621-624.
22. Kemler R. Classical cadherins Semin Cell Biol 3 1992 149-155.
23. Lampugnani M.G. Resnati M. Raiteri M. Pigott R. Pisacane A. Houen G. et-al A novel endothelial-specific membrane protein is a marker of cell-cell contacts J Cell Biol 118 1992 1511-1522.
24. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis Cell 4 1996 345-357.
25. Pasquale E.B. The Eph family of receptors Curr Opin Cell Biol 9 1997 608-615.
26. Rosenburg I.M. Goke M. Kanai M. Reinecker H.C. Podolsky D.K. Epithelial cell kinase-B-61: an autocrine loop modulating intestinal epithelial migration and barrier function Am J Physiol 273 4 part 1 1997 G824-G832.
27. Straume O. Akslen L.A. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and Ephrin-A1/EphA2 on melanoma progression Am J Pathol 160 3 2001 1009-1019.
28. Colognato H. Yurchenco P.D. Form and function: the laminin family of heterotrimers Dev Dyn 218 2001 213-234.
29. Malinda K.M. Kleinman H.K. The laminins Int J Biochem Cell Biol 28 9 1996 957-995.
30. Malinda K.M. Motoyoshi N. Melissa C. Delgado M. Kuratomi Y. Yamada Y. et-al Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting FASEB J 13 1999 53-62.
31. Koshikawa N. Giannelli G. Cirulli V. Miyazaki K. Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5 J Cell Biol 148 2000 615-624.
32. Giannelli G. Falk-Marzillier J. Schiraldi O. Stetler-Stevenson W.G. Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 Science 277 1997 225-228.
33. Seftor E.A. Meltzer P.S. Schatteman G.C. Gruman L.M. Hess A.R. Kirschmann D.A. et-al Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry Crit Rev Oncol Hematol In press 2002.
34. Salih H.R. Nussler V. Commentary: immune escape versus tumor tolerance: how do tumor evade immune surveillance? Eur J Med Res 6 8 2001 323-332.
35. Smyth M.J. Godfrey D.I. Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy Nat Immunol 2 2001 293-299.
36. Jager M.J. Hurks H.M.H. Levitskaya J. Kiessling R. HLA expression in uveal melanoma: there is no rule without some exceptions Hum Immunol 63 2002 444-451.
37. Ferrone S. Marinocola F.M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance Immunol Today 16 1995 487-494.
38. Bröcker E.B. Suter L. Brügger J. Ruiter D.J. Macher E. Sorg C. Phenotypic dynamics of tumor progression in human malignant melanoma Int J Cancer 36 1985 29-35.
39. Kaklamanis L. Gatter K.C. Hill A.B. Mortensen N. Haris A.L. Krausa P. et-al Loss of HLA class I alleles, heavy chains and beta 2 microglobulin in colorectal cancer Int J Cancer 51 1992 379-385.
40. Bicknell D.C. Rowan A. Bodmer W.F. Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors Proc Natl Acad Sci USA 91 1994 4751-4756.
41. Rock K.L. Golberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides Annu Rev Immunol 17 1999 739-779.
42. Seliger B. Maeurer M.J. Ferrone S. Antigen-processing machinery breakdown and tumor growth Immunol Today 21 2000 455-464.
43. Kageshita T. Hirai S. Ono T. Hicklin D.J. Ferrone S. Down-regulation of HLA-class I antigen-processing molecules in malignant melanoma: association with disease progression Am J Pathol 154 1999 745-754.
44. Murray J.L. Hudson J.M. Ross M.I. Zhang H.Z. Ioannides C.G. Reduced recognition of metastatic melanoma cells by autologous MART-1 specific CTL: relationship to TAP expression J Immunother 23 2000 28-35.
45. Kamarashev J. Ferrone S. Seifert B. Boni R. Nestle F.O. Burg G. et-al TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis Int J Cancer 95 2001 23-28.
46. Blom D.J.R. Luyten G.P.M. Mooy C. Kerkvliet S. Zwinderman A.H. Jager M.J. Human leukocyte antigen class I expression: marker of poor prognosis in uveal melanoma Invest Ophthalmol Vis Sci 38 1997 1865-1872.
47. Blom D.J.R. Mooy C.M. Luyten G.P.M. Kerkvliet S. Ouwerkerk I. Zwinderman A.H. et-al Inverse correlation between expression of HLA-B and c-myc in uveal melanoma J Pathol 181 1997 75-79.
48. Ericsson C. Seregard S. Bartolazzi A. Levitskaya E. Ferrone S. Kiessling R. et-al Association of HLA class I and class II antigen expression and mortality in uveal melanoma Invest Ophthalmol Vis Sci 42 2001 2153-2156.
49. Ugurel S. Reinhold U. Tilgen W. HLA-G in melanoma: a new strategy to escape from immunosurveillance? Onkologie 25 2002 129-134.
50. Riteau B. Menier C. Kalil-Daher I. Martinozzi S. Pla M. Dausset J. et-al HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition Int Immunol 13 2001 193-201.